All Stories

  1. Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

    Article • Leukemia, September 2021, Springer Science + Business Media

    Christian Thiede

  2. The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

    Article • Clinical Colorectal Cancer, September 2021, Elsevier

    Christian Thiede

  3. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

    Article • Blood Advances, August 2021, American Society of Hematology

    Christian Thiede

  4. Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

    Article • Leukemia, July 2021, Springer Science + Business Media

    Christian Thiede

  5. Clonal hematopoiesis and its emerging effects on cellular therapies

    Article • Leukemia, July 2021, Springer Science + Business Media

    Christian Thiede

  6. Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns

    Article • Leukemia, June 2021, Springer Science + Business Media

    Christian Thiede

  7. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

    Article • Blood, May 2021, American Society of Hematology

    Christian Thiede

  8. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response

    Article • Nature Cancer, May 2021, Springer Science + Business Media

    Christian Thiede

  9. Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia

    Article • Cancers, April 2021, MDPI AG

    Christian Thiede

  10. Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q

    Article • American Journal of Hematology, April 2021, Wiley

    Christian Thiede

  11. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

    Article • Leukemia, March 2021, Springer Science + Business Media

    Christian Thiede

  12. Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

    Article • Leukemia, February 2021, Springer Science + Business Media

    Christian Thiede

  13. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study*

    Article • British Journal of Haematology, February 2021, Wiley

    Christian Thiede

  14. Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis

    Article • Leukemia & Lymphoma, January 2021, Taylor & Francis

    Christian Thiede

  15. Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma

    Article • Neoplasia, December 2020, Elsevier

    Christian Thiede

  16. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

    Article • Blood Advances, October 2020, American Society of Hematology

    Christian Thiede

  17. Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells

    Article • Blood, September 2020, American Society of Hematology

    Christian Thiede

  18. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Article • Journal of Clinical Oncology, September 2020, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  19. Differential response to cytotoxic therapy explains treatment dynamics of acute myeloid leukaemia patients: insights from a mathematical modelling approach

    Article • Journal of The Royal Society Interface, September 2020, Royal Society Publishing

    Christian Thiede

  20. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

    Article • Blood, August 2020, American Society of Hematology

    Christian Thiede

  21. Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia

    Article • Biomarker Research, June 2020, Springer Science + Business Media

    Christian Thiede

  22. Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation

    Article • Annals of Hematology, February 2020, Springer Science + Business Media

    Christian Thiede

  23. Differential response to cytotoxic therapy explains treatment dynamics of AML patients: insights from a mathematical modelling approach

    Article • February 2020, Cold Spring Harbor Laboratory Press

    Christian Thiede

  24. Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology

    Article • BMC Medical Informatics and Decision Making, February 2020, Springer Science + Business Media

    Christian Thiede

  25. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

    Article • Blood, January 2020, American Society of Hematology

    Christian Thiede

  26. The clinical mutatome of core binding factor leukemia

    Article • Leukemia, January 2020, Springer Science + Business Media

    Christian Thiede

  27. Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy

    Article • Current Treatment Options in Oncology, January 2020, Springer Science + Business Media

    Christian Thiede

  28. Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

    Article • Leukemia, December 2019, Springer Science + Business Media

    Christian Thiede

  29. Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia

    Article • Cancers, October 2019, MDPI AG

    Christian Thiede

  30. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

    Article • Leukemia, October 2019, Springer Science + Business Media

    Christian Thiede

  31. Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

    Article • Journal of Clinical Oncology, October 2019, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  32. EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia

    Article • Haematologica, August 2019, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  33. Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

    Article • Haematologica, April 2019, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  34. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation

    Article • Journal of Clinical Oncology, February 2019, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  35. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer

    Article • Clinical Biochemistry, February 2019, Elsevier

    Christian Thiede

  36. The prognostic potential of monitoring disease dynamics in NPM1-positive acute myeloid leukemia

    Article • Leukemia, January 2019, Springer Science + Business Media

    Christian Thiede

  37. Characterization of acute myeloid leukemia with del(9q) – Impact of the genes in the minimally deleted region

    Article • Leukemia Research, January 2019, Elsevier

    Christian Thiede

  38. Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups

    Article • Journal of Neuro-Oncology, December 2018, Springer Science + Business Media

    Christian Thiede

  39. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

    Article • The Lancet Oncology, December 2018, Elsevier

    Christian Thiede

  40. JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter

    Article • Cancer Research, October 2018, American Association for Cancer Research (AACR)

    Christian Thiede

  41. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial

    Article • Journal of Gastroenterology, October 2018, Springer Science + Business Media

    Christian Thiede

  42. Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, September 2018, Elsevier

    Christian Thiede

  43. Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

    Article • Nature, August 2018, Springer Science + Business Media

    Christian Thiede

  44. Germ line predisposition to myeloid malignancies appearing in adulthood

    Article • Expert Review of Hematology, July 2018, Taylor & Francis

    Christian Thiede

  45. TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study

    Article • Clinical Cancer Research, June 2018, American Association for Cancer Research (AACR)

    Christian Thiede

  46. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association

    Article • Leukemia, June 2018, Springer Science + Business Media

    Christian Thiede

  47. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

    Article • Leukemia, June 2018, Springer Science + Business Media

    Christian Thiede

  48. Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

    Article • Blood Advances, May 2018, American Society of Hematology

    Christian Thiede

  49. An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants

    Article • Biomolecular Detection and Quantification, May 2018, Elsevier

    Christian Thiede

  50. Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients

    Article • Annals of Oncology, April 2018, Elsevier

    Christian Thiede

  51. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    Article • Blood, March 2018, American Society of Hematology

    Christian Thiede

  52. miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia

    Article • Blood Cancer Journal, March 2018, Springer Science + Business Media

    Christian Thiede

  53. Pilot Study on Mass Spectrometry–Based Analysis of the Proteome of CD34+CD123+ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia

    Article • Proteomes, February 2018, MDPI AG

    Christian Thiede

  54. Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas

    Article • Oncotarget, November 2017, Impact Journals, LLC

    Christian Thiede, Hiroaki Wakimoto

  55. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

    Article • Nature, November 2017, Springer Science + Business Media

    Christian Thiede

  56. Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative forFLT3-ITD,NPM1- or biallelicCEBPA mutations

    Article • Annals of Oncology, November 2017, Elsevier

    Christian Thiede

  57. Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations

    Article • Oncotarget, October 2017, Impact Journals, LLC

    Christian Thiede

  58. Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients

    Article • European Journal Of Haematology, October 2017, Wiley

    Christian Thiede

  59. Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia—Lessons Learned from the Prospective BRIDGE Trial

    Article • Biology of Blood and Marrow Transplantation, September 2017, Elsevier

    Christian Thiede

  60. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with aFLT3Mutation

    Article • New England Journal of Medicine, August 2017, New England Journal of Medicine (NEJM/MMS)

    Christian Thiede

  61. Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas

    Article • Journal of Neurosurgery, August 2017, Journal of Neurosurgery Publishing Group (JNSPG)

    PD Dr. med. Tareq Juratli, Christian Thiede

  62. Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

    Article • Leukemia, July 2017, Springer Science + Business Media

    Christian Thiede

  63. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation

    Article • Annals of Hematology, June 2017, Springer Science + Business Media

    Christian Thiede

  64. Dynamics of epigenetic age following hematopoietic stem cell transplantation

    Article • Haematologica, May 2017, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  65. Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

    Article • Blood, May 2017, American Society of Hematology

    Christian Thiede

  66. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004

    Article • Leukemia, April 2017, Springer Science + Business Media

    Christian Thiede

  67. Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape

    Article • Leukemia, April 2017, Springer Science + Business Media

    Christian Thiede

  68. Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient

    Article • Leukemia, March 2017, Springer Science + Business Media

    Christian Thiede

  69. Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

    Article • Leukemia, March 2017, Springer Science + Business Media

    Christian Thiede

  70. Akute myeloische Leukämie

    Article • Der Onkologe, March 2017, Springer Science + Business Media

    Christian Thiede

  71. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    Article • Journal of Clinical Oncology, February 2017, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  72. Lipidomic approach for stratification of acute myeloid leukemia patients

    Article • PLoS ONE, February 2017, PLOS

    Christian Thiede

  73. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

    Article • Blood, January 2017, American Society of Hematology

    Dr Friedrich Stölzel, Christian Thiede

  74. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

    Article • Nature Reports Stem Cells, December 2016, Springer Science + Business Media

    Christian Thiede

  75. Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy

    Article • Haematologica, November 2016, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  76. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features

    Article • Biology of Blood and Marrow Transplantation, November 2016, Elsevier

    Christian Thiede

  77. Inactivation of Cancer Mutations Utilizing CRISPR/Cas9

    Article • JNCI Journal of the National Cancer Institute, August 2016, Oxford University Press (OUP)

    Christian Thiede

  78. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups

    Article • Cancer, August 2016, Wiley

    Christian Thiede

  79. Finding small somatic structural variants in exome sequencing data: a machine learning approach

    Article • Computational Statistics, August 2016, Springer Science + Business Media

    Christian Thiede

  80. Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia

    Article • Blood Cancer Journal, July 2016, Springer Science + Business Media

    Christian Thiede

  81. ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation

    Article • Nature Communications, June 2016, Springer Science + Business Media

    Christian Thiede

  82. Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD

    Article • Biology of Blood and Marrow Transplantation, March 2016, Elsevier

    Christian Thiede

  83. GFI1 as a novel prognostic and therapeutic factor for AML/MDS

    Article • Leukemia, February 2016, Nature

    Dr André Görgens, Christian Thiede

  84. TP53mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

    Article • British Journal of Haematology, January 2016, Wiley

    Christian Thiede

  85. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

    Article • The Lancet Oncology, December 2015, Elsevier

    Christian Thiede

  86. MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells

    Article • Oncogenesis, December 2015, Springer Science + Business Media

    Christian Thiede

  87. Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia

    Article • Leukemia, November 2015, Springer Science + Business Media

    Christian Thiede

  88. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia

    Article • Leukemia, November 2015, Springer Science + Business Media

    Christian Thiede

  89. Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia

    Article • Oncotarget, October 2015, Impact Journals, LLC

    Christian Thiede

  90. MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML

    Article • Experimental Hematology, September 2015, Elsevier

    Christian Thiede

  91. Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

    Article • Leukemia, August 2015, Springer Science + Business Media

    Christian Thiede

  92. Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors

    Article • Transfusion, July 2015, Wiley

    Christian Thiede

  93. Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden

    Article • Leukemia, June 2015, Springer Science + Business Media

    Christian Thiede

  94. Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?

    Article • Annals of Hematology, April 2015, Springer Science + Business Media

    Christian Thiede

  95. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

    Article • Leukemia, February 2015, Springer Science + Business Media

    Christian Thiede

  96. Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial

    Article • Journal of Clinical Oncology, February 2015, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  97. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia

    Article • Haematologica, December 2014, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  98. Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

    Article • Leukemia, December 2014, Springer Science + Business Media

    Christian Thiede

  99. Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring

    Article • Haematologica, November 2014, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  100. Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial

    Article • Annals of Hematology, November 2014, Springer Science + Business Media

    Christian Thiede

  101. Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia

    Article • Haematologica, September 2014, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  102. Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

    Article • Blood Cancer Journal, June 2014, Springer Science + Business Media

    Christian Thiede

  103. Low frequency of calreticulin mutations in MDS patients

    Article • Leukemia, May 2014, Springer Science + Business Media

    Christian Thiede

  104. Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia

    Article • Pediatric Blood & Cancer, May 2014, Wiley

    Christian Thiede

  105. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

    Article • Leukemia, February 2014, Springer Science + Business Media

    Christian Thiede

  106. Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

    Article • Blood, February 2014, American Society of Hematology

    Christian Thiede

  107. Monitoring of acute myeloid leukemia patients after allogeneic stem cell transplantation employing semi-automated CD34+ donor cell chimerism analysis

    Article • Annals of Hematology, December 2013, Springer Science + Business Media

    Christian Thiede

  108. Sex and Body Mass Index but Not CXCL12 801 G/A Polymorphism Determine the Efficacy of Hematopoietic Cell Mobilization: A Study in Healthy Volunteer Donors

    Article • Biology of Blood and Marrow Transplantation, October 2013, Elsevier

    Christian Thiede

  109. Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

    Article • Journal of Clinical Oncology, September 2013, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  110. Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation

    Article • Blood Cancer Journal, August 2013, Springer Science + Business Media

    Christian Thiede

  111. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    Article • New England Journal of Medicine, July 2013, New England Journal of Medicine (NEJM/MMS)

    Christian Thiede

  112. The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML

    Article • Blood, July 2013, American Society of Hematology

    Christian Thiede

  113. High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 Trial

    Article • Journal of Clinical Oncology, June 2013, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  114. Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis

    Article • Case Reports in Oncology, June 2013, Karger Publishers

    Christian Thiede

  115. Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia

    Article • Leukemia, May 2013, Springer Science + Business Media

    Christian Thiede

  116. SETBP1 mutation analysis in 944 patients with MDS and AML

    Article • Leukemia, May 2013, Springer Science + Business Media

    Christian Thiede

  117. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation

    Article • Experimental Hematology, May 2013, Elsevier

    Christian Thiede

  118. In Vivo Expansion of Co-Transplanted T Cells Impacts on Tumor Re-Initiating Activity of Human Acute Myeloid Leukemia in NSG Mice

    Article • PLoS ONE, April 2013, PLOS

    Christian Thiede

  119. Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals via K-Ras at the plasma membrane of Acute Myeloid Leukemia cells

    Article • Journal of Cell Science, January 2013, The Company of Biologists

    Christian Thiede

  120. Feasibility of Azacitidine Added to Standard Chemotherapy in Older Patients with Acute Myeloid Leukemia — A Randomised SAL Pilot Study

    Article • PLoS ONE, December 2012, PLOS

    Christian Thiede

  121. Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells

    Article • BMC Cancer, December 2012, Springer Science + Business Media

    Christian Thiede

  122. Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML

    Article • Blood, November 2012, American Society of Hematology

    Christian Thiede

  123. Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarate

    Article • Acta Neuropathologica, November 2012, Springer Science + Business Media

    Christian Thiede

  124. Second Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 Years

    Article • Gastroenterology, October 2012, Elsevier

    Christian Thiede

  125. Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial

    Article • Haematologica, September 2012, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  126. Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia

    Article • Genes Chromosomes and Cancer, August 2012, Wiley

    Christian Thiede

  127. Reconstitution of 6-Sulfo LacNAc Dendritic Cells After Allogeneic Stem-Cell Transplantation

    Article • Transplantation, June 2012, Wolters Kluwer Health

    Christian Thiede

  128. Mutant DNMT3A: teaming up to transform

    Article • Blood, June 2012, American Society of Hematology

    Christian Thiede

  129. Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Transplantation, April 2012, Wolters Kluwer Health

    Dr Friedrich Stölzel, Christian Thiede

  130. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene

    Article • Blood, March 2012, American Society of Hematology

    Christian Thiede

  131. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

    Article • The Lancet Oncology, February 2012, Elsevier

    Christian Thiede

  132. Befundinterpretation der molekularen Diagnostik in der Verlaufskontrolle der chronischen myeloischen Leukämie: Empfehlungen einer deutschen Expertengruppe/Interpretation of molecular diagnostics results in routine monitoring for chronic myeloid leukemi...

    Article • LaboratoriumsMedizin, January 2012, De Gruyter

    Christian Thiede

  133. Übersicht – Molekulare Pathogenese und Diagnostik der akuten myeloischen Leukämie

    Article • TumorDiagnostik & Therapie, December 2011, Thieme Publishing Group

    Christian Thiede

  134. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia

    Article • Experimental Hematology, October 2011, Elsevier

    Dr Friedrich Stölzel, Christian Thiede

  135. Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

    Article • Leukemia, September 2011, Springer Science + Business Media

    Christian Thiede

  136. Targeted isolation of cloned genomic regions by recombineering for haplotype phasing and isogenic targeting

    Article • Nucleic Acids Research, August 2011, Oxford University Press (OUP)

    Christian Thiede

  137. Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse

    Article • Haematologica, July 2011, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  138. Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System

    Article • Journal of Clinical Oncology, July 2011, American Society of Clinical Oncology (ASCO)

    Dr Friedrich Stölzel, Christian Thiede

  139. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)

    Article • Annals of Hematology, July 2011, Springer Science + Business Media

    Christian Thiede

  140. Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study

    Article • Journal of Clinical Oncology, July 2011, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  141. Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

    Article • Blood, June 2011, American Society of Hematology

    Christian Thiede

  142. Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups

    Article • Leukemia, June 2011, Springer Science + Business Media

    Christian Thiede

  143. Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?

    Article • Haematologica, June 2011, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  144. Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival

    Article • Leukemia Research, May 2011, Elsevier

    Christian Thiede

  145. Reply to: ‘Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity’ by Kern et al.

    Article • Leukemia, February 2011, Springer Science + Business Media

    Christian Thiede

  146. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT

    Article • Gut, February 2011, BMJ

    Christian Thiede

  147. Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy

    Article • Leukemia, February 2011, Springer Science + Business Media

    Christian Thiede

  148. Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

    Article • Leukemia, December 2010, Springer Science + Business Media

    Christian Thiede

  149. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

    Article • The Lancet, December 2010, Elsevier

    Christian Thiede

  150. Genetic Variations of Interleukin-23R (1143A>G) and BPI (A645G), but Not of NOD2, Are Associated with Acute Graft-versus-Host Disease after Allogeneic Transplantation

    Article • Biology of Blood and Marrow Transplantation, December 2010, Elsevier

    Christian Thiede

  151. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice

    Article • Blood, November 2010, American Society of Hematology

    Christian Thiede

  152. Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

    Article • Blood, November 2010, American Society of Hematology

    Christian Thiede

  153. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia

    Article • Blood, November 2010, American Society of Hematology

    Christian Thiede

  154. Immunohistochemical Surrogates for Genetic Alterations of CCDN1, PML, ALK, and NPM1 Genes in Lymphomas and Acute Myeloid Leukemia

    Article • Best Practice & Research Clinical Haematology, September 2010, Elsevier

    Christian Thiede

  155. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia

    Article • Leukemia, August 2010, Springer Science + Business Media

    Christian Thiede

  156. A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

    Article • Blood, August 2010, American Society of Hematology

    Christian Thiede

  157. Mixed Lymphohematopoietic Chimerism and Response in Wegener's Granulomatosis

    Article • New England Journal of Medicine, June 2010, New England Journal of Medicine (NEJM/MMS)

    Christian Thiede

  158. Pim2 cooperates with PML-RARα to induce acute myeloid leukemia in a bone marrow transplantation model

    Article • Blood, June 2010, American Society of Hematology

    Christian Thiede

  159. Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways

    Article • Leukemia, April 2010, Springer Science + Business Media

    Christian Thiede

  160. A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia

    Article • Blood, March 2010, American Society of Hematology

    Christian Thiede

  161. 188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning andin-vivoT cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation

    Article • British Journal of Haematology, March 2010, Wiley

    Christian Thiede

  162. Impact of CXCR4 inhibition on FLT3-ITD−positive human AML blasts

    Article • Experimental Hematology, March 2010, Elsevier

    Christian Thiede

  163. General Transcription Factor Binding at CpG Islands in Normal Cells Correlates with Resistance to De novo DNA Methylation in Cancer Cells

    Article • Cancer Research, February 2010, American Association for Cancer Research (AACR)

    Christian Thiede

  164. Impact of the type of the BCR-ABL fusion transcript on the molecular response in pediatric patients with chronic myeloid leukemia

    Article • Haematologica, February 2010, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  165. Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells

    Article • Annals of Hematology, January 2010, Springer Science + Business Media

    Dr Friedrich Stölzel, Christian Thiede

  166. WHO classification of myeloid neoplasms and leukemia

    Article • Blood, January 2010, American Society of Hematology

    Christian Thiede

  167. Quantitative comparison of microarray experiments with published leukemia related gene expression signatures

    Article • BMC Bioinformatics, December 2009, Springer Science + Business Media

    Christian Thiede

  168. Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation

    Article • Leukemia Research, December 2009, Elsevier

    Christian Thiede

  169. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation

    Article • Haematologica, October 2009, Ferrata Storti Foundation (Haematologica)

    Professor Michael G Kiehl, Christian Thiede

  170. Mobilization of PML/RAR  negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide

    Article • Haematologica, October 2009, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  171. Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine

    Article • Leukemia, September 2009, Springer Science + Business Media

    Christian Thiede

  172. HLA-DRnegpatients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia

    Article • Cytometry Part B Clinical Cytometry, September 2009, Wiley

    Christian Thiede

  173. Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML

    Article • Leukemia Research, July 2009, Elsevier

    Christian Thiede

  174. SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival

    Article • Leukemia, May 2009, Springer Science + Business Media

    Christian Thiede

  175. Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics

    Article • American Journal of Hematology, May 2009, Wiley

    Christian Thiede

  176. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality

    Article • Blood, April 2009, American Society of Hematology

    Christian Thiede

  177. The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells

    Article • Haematologica, March 2009, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  178. Efficient Production of Bioactive Recombinant Human Flt3 Ligand in E. coli

    Article • Journal of Protein Chemistry, January 2009, Springer Science + Business Media

    Christian Thiede

  179. The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

    Article • Leukemia, January 2009, Springer Science + Business Media

    Christian Thiede

  180. Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial

    Article • Biology of Blood and Marrow Transplantation, January 2009, Elsevier

    Christian Thiede

  181. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

    Article • Leukemia, November 2008, Springer Science + Business Media

    Christian Thiede

  182. Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group

    Article • Journal of Clinical Oncology, November 2008, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  183. Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study

    Article • Journal of Clinical Oncology, October 2008, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  184. Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia

    Article • Clinical Cancer Research, September 2008, American Association for Cancer Research (AACR)

    Christian Thiede

  185. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)

    Article • Haematologica, August 2008, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  186. Cyclic severe elevated procalcitonin serum levels in a patient with post polycythemic myelofibrosis carrying a V617F-JAK2 mutation

    Article • Annals of Hematology, June 2008, Springer Science + Business Media

    Christian Thiede

  187. MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients

    Article • Blood, February 2008, American Society of Hematology

    Christian Thiede

  188. Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

    Article • Haematologica, February 2008, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  189. Abnormal Localization and Accumulation of FLT3-ITD, a Mutant Receptor Tyrosine Kinase Involved in Leukemogenesis

    Article • Cells Tissues Organs, January 2008, Karger Publishers

    Christian Thiede

  190. Identification of acute myeloid leukaemia associated microRNA expression patterns

    Article • British Journal of Haematology, December 2007, Wiley

    Christian Thiede

  191. Molekulare Pathogenese gastrointestinaler Lymphome

    Article • Verdauungskrankheiten, November 2007, Dustri-Verlgag Dr. Karl Feistle

    Christian Thiede

  192. A highly sensitive method for the detection of PKC412 (CGP41251) and its metabolites by high-performance liquid chromatography

    Article • Journal of Pharmacological and Toxicological Methods, July 2007, Elsevier

    Christian Thiede

  193. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis

    Article • Leukemia, May 2007, Springer Science + Business Media

    Christian Thiede

  194. Class I HDAC SNP analysis in healthy donors compared to AML patients

    Article • Leukemia, April 2007, Springer Science + Business Media

    Christian Thiede

  195. Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML

    Article • Blood, March 2007, American Society of Hematology

    Christian Thiede

  196. Therapy of gastric mucosa associated lymphoid tissue lymphoma

    Article • World Journal of Gastroenterology, January 2007, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Christian Thiede

  197. Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias

    Article • Haematologica, January 2007, Ferrata Storti Foundation (Haematologica)

    Christian Thiede

  198. Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12

    Article • Leukemia, December 2006, Springer Science + Business Media

    Christian Thiede

  199. Association with the single-nucleotide polymorphism (Glu785Lys) of the granulocyte colony-stimulating factor receptor with myelodysplastic syndromes and acute myeloid leukemia with multlineage dysplasia

    Article • Leukemia, October 2006, Springer Science + Business Media

    Christian Thiede

  200. Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping

    Article • Leukemia, September 2006, Springer Science + Business Media

    Christian Thiede

  201. Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

    Article • Leukemia, August 2006, Springer Science + Business Media

    Christian Thiede

  202. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)

    Article • Blood, May 2006, American Society of Hematology

    Christian Thiede

  203. Further sequence data of allelic variants at the STR locus ACTBP2 (SE33): Detection of a very short off ladder allele

    Article • International Congress Series, April 2006, Elsevier

    Christian Thiede

  204. Fast Appearance of Donor Dendritic Cells in Human Skin: Dynamics of Skin and Blood Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation

    Article • Transplantation, March 2006, Wolters Kluwer Health

    Christian Thiede

  205. Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia

    Article • Leukemia, February 2006, Springer Science + Business Media

    Christian Thiede

  206. BAALC Expression and FLT3 Internal Tandem Duplication Mutations in Acute Myeloid Leukemia Patients With Normal Cytogenetics: Prognostic Implications

    Article • Journal of Clinical Oncology, February 2006, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  207. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia

    Article • Leukemia, January 2006, Springer Science + Business Media

    Christian Thiede

  208. Acute graft-versus-host disease of the heart

    Article • Pediatric Blood & Cancer, January 2006, Wiley

    Christian Thiede

  209. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication

    Article • Gut, January 2006, BMJ

    Christian Thiede

  210. Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication

    Article • Journal of Clinical Oncology, November 2005, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  211. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission

    Article • Bone Marrow Transplantation, October 2005, Springer Science + Business Media

    Christian Thiede

  212. Gene-Expression Profiling of CD34+ Hematopoietic Cells Expanded in a Collagen I Matrix

    Article • Stem Cells, September 2005, Oxford University Press (OUP)

    Christian Thiede

  213. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue

    Article • Annals of Hematology, August 2005, Springer Science + Business Media

    Christian Thiede

  214. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model

    Article • Blood, June 2005, American Society of Hematology

    Christian Thiede

  215. Activation of the RAS Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts

    Article • Clinical Cancer Research, May 2005, American Association for Cancer Research (AACR)

    Christian Thiede

  216. Activity of sirolimus in patients with myelodysplastic syndrome - results of a pilot study

    Article • British Journal of Haematology, March 2005, Wiley

    DR Matthias Orth, Christian Thiede

  217. RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation

    Article • Blood, March 2005, American Society of Hematology

    Christian Thiede

  218. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia

    Article • British Journal of Haematology, February 2005, Wiley

    Christian Thiede

  219. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated withCEBPAloss-of-function mutations

    Article • Genes Chromosomes and Cancer, January 2005, Wiley

    Christian Thiede

  220. Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability

    Article • World Journal of Gastroenterology, January 2005, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Christian Thiede

  221. Hematopoietic stem cell transplantation for complete IFN-γ receptor 1 deficiency: A multi-institutional survey

    Article • The Journal of Pediatrics, December 2004, Elsevier

    Christian Thiede

  222. Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells

    Article • Leukemia, October 2004, Springer Science + Business Media

    Christian Thiede

  223. CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation

    Article • Bone Marrow Transplantation, October 2004, Springer Science + Business Media

    Christian Thiede

  224. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+cells: down-regulation upon myeloid differentiation

    Article • Journal of Leukocyte Biology, August 2004, Wiley

    Christian Thiede

  225. Diagnostic Chimerism Analysis After Allogeneic Stem Cell Transplantation

    Article • American Journal of PharmacoGenomics, January 2004, Springer Science + Business Media

    Christian Thiede

  226. Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Acta Haematologica, January 2004, Karger Publishers

    Christian Thiede

  227. Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation – a retrospective analysis

    Article • Bone Marrow Transplantation, December 2003, Springer Science + Business Media

    Professor Michael G Kiehl, Christian Thiede

  228. Evaluation of STR informativity for chimerism testing – comparative analysis of 27 STR systems in 203 matched related donor recipient pairs

    Article • Leukemia, December 2003, Springer Science + Business Media

    Christian Thiede

  229. Etiology and therapy of Helicobacter pylori -associated gastric lymphomas

    Article • Annals of Hematology, September 2003, Springer Science + Business Media

    Christian Thiede

  230. Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

    Article • Blood, August 2003, American Society of Hematology

    Christian Thiede

  231. Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group

    Article • Journal of Clinical Oncology, July 2003, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  232. Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor

    Article • Blood, July 2003, American Society of Hematology

    Christian Thiede

  233. B-cell Monoclonality Is Associated With Lymphoid Follicles in Gastritis

    Article • The American Journal of Surgical Pathology, July 2003, Wolters Kluwer Health

    Christian Thiede

  234. Immunophenotyping is an independent factor for risk stratification in AML

    Article • Cytometry, April 2003, Wiley

    Christian Thiede

  235. Comparative analysis ofMLLpartial tandem duplication andFLT3internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia

    Article • Genes Chromosomes and Cancer, April 2003, Wiley

    Christian Thiede

  236. Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantation

    Article • Bone Marrow Transplantation, April 2003, Springer Science + Business Media

    Christian Thiede

  237. Successful combination of anti-cd33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia

    Article • British Journal of Haematology, March 2003, Wiley

    Christian Thiede

  238. Evidence for a graft-versus-tumor effect in refractory ovarian cancer

    Article • Journal of Cancer Research and Clinical Oncology, January 2003, Springer Science + Business Media

    Christian Thiede

  239. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma

    Article • Annals of Hematology, January 2003, Springer Science + Business Media

    Christian Thiede

  240. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34+ measurements and timing of leukaphereses

    Article • Cytotherapy, January 2003, Elsevier

    Christian Thiede

  241. Correction of complete interferon-γ receptor 1 deficiency by bone marrow transplantation

    Article • Blood, December 2002, American Society of Hematology

    Christian Thiede

  242. Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia

    Article • European Journal Of Haematology, July 2002, Wiley

    Christian Thiede

  243. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

    Article • Blood, June 2002, American Society of Hematology

    Christian Thiede

  244. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

    Article • Gastroenterology, May 2002, Elsevier

    Christian Thiede

  245. Helicobacter and gastric MALT lymphoma

    Article • Gut, May 2002, BMJ

    Christian Thiede

  246. Bedeutung der Helicobacter-pylori-Infektion für die Pathogenese und Therapie von MALT-Lymphomen des Magens

    Article • Visceral Medicine, January 2002, Karger Publishers

    Christian Thiede

  247. Long-term follow-up of gastric malt lymphoma after H. pylori eradication

    Article • Current Gastroenterology Reports, December 2001, Springer Science + Business Media

    Christian Thiede

  248. Molecular Diagnostics in Low-Grade Gastric Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type After Helicobacter pylori Eradication Therapy

    Article • Clinical Lymphoma, September 2001, Elsevier

    Christian Thiede

  249. Are lymphocytic monoclonality and immunoglobulin heavy chain (IgH) rearrangement premalignant conditions in chronic gastritis?

    Article • Microscopy Research and Technique, June 2001, Wiley

    Christian Thiede

  250. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals

    Article • Cancer Genetics and Cytogenetics, June 2001, Elsevier

    Christian Thiede

  251. SUCCESSFUL PREEMPTIVE CIDOFOVIR TREATMENT FOR CMV ANTIGENEMIA AFTER DOSE-REDUCED CONDITIONING AND ALLOGENEIC BLOOD STEM CELL TRANSPLANTATION

    Article • Transplantation, April 2001, Wolters Kluwer Health

    Christian Thiede

  252. Complete Remission of Primary High-Grade B-Cell Gastric Lymphoma After Cure of Helicobacter pylori Infection

    Article • Journal of Clinical Oncology, April 2001, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  253. Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma

    Article • Journal of Clinical Oncology, March 2001, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  254. Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

    Article • Bone Marrow Transplantation, March 2001, Springer Science + Business Media

    Christian Thiede

  255. Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia

    Article • British Journal of Haematology, February 2001, Wiley

    Christian Thiede

  256. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

    Article • Leukemia, February 2001, Springer Science + Business Media

    Christian Thiede

  257. Quantitative analysis of chimerism after allogeneic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers and fluorescence detection

    Article • Leukemia, February 2001, Springer Science + Business Media

    Christian Thiede

  258. Somatic hypermutation and B-cell lymphoma

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, January 2001, Royal Society Publishing

    Professor Deborah K Dunn-Walters, Christian Thiede

  259. Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF

    Article • Annals of Hematology, January 2001, Springer Science + Business Media

    Christian Thiede

  260. Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin

    Article • Bone Marrow Transplantation, January 2001, Springer Science + Business Media

    Christian Thiede

  261. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type

    Article • World Journal of Gastroenterology, January 2001, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Christian Thiede

  262. Determination of Mycophenolic Acid and Mycophenolate Mofetil by High-Performance Liquid Chromatography Using Postcolumn Derivatization

    Article • Analytical Chemistry, November 2000, American Chemical Society (ACS)

    Christian Thiede

  263. Quality assurance in RT-PCR-based BCR/ABL diagnostics – results of an interlaboratory test and a standardization approach

    Article • Leukemia, October 2000, Springer Science + Business Media

    Christian Thiede

  264. Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

    Article • Bone Marrow Transplantation, July 2000, Springer Science + Business Media

    Christian Thiede

  265. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication ofHelicobacter pylori infection

    Article • Blood, June 2000, American Society of Hematology

    Christian Thiede

  266. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome

    Article • Leukemia, June 2000, Springer Science + Business Media

    Christian Thiede

  267. Helicobacter heilmannii–associated primary gastric low-grade MALT lymphoma: Complete remission after curing the infection

    Article • Gastroenterology, May 2000, Elsevier

    Christian Thiede

  268. Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants

    Article • Bone Marrow Transplantation, March 2000, Springer Science + Business Media

    Christian Thiede

  269. Forum: Letters to the Editor

    Article • Cytometry, January 2000, Wiley

    Christian Thiede

  270. Lack of Point Mutations in Exons 11–23 of the Retinoblastoma Susceptibility Gene RB-1 in Liver Metastases of Colorectal Carcinoma

    Article • Oncology, January 2000, Karger Publishers

    Christian Thiede

  271. Facilitated detection of oncogene mutations from exfoliated tissue material by a PNA-mediated ?enriched PCR? protocol

    Article • The Journal of Pathology, January 2000, Wiley

    Christian Thiede

  272. Eradication of Helicobacter pylori and Stability of Remissions in Low-Grade Gastric B-Cell Lymphomas of the Mucosa-Associated Lymphoid Tissue: Results of an Ongoing Multicenter Trial

    Article • January 2000, Springer Science + Business Media

    Christian Thiede

  273. STABLE ENGRAFTMENT AFTER MEGADOSE BLOOD STEM CELL TRANSPLANTATION ACROSS THE HLA BARRIER

    Article • Transplantation, July 1999, Wolters Kluwer Health

    Christian Thiede

  274. Erratum: Onkologe 5: 450–455 (1999)

    Article • Der Onkologe, July 1999, Springer Science + Business Media

    Christian Thiede

  275. Dosisintensität und Zelltod

    Article • Der Onkologe, May 1999, Springer Science + Business Media

    Christian Thiede

  276. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

    Article • Bone Marrow Transplantation, May 1999, Springer Science + Business Media

    Christian Thiede

  277. Chimerism Following Donor Lymphocyte Infusion for Chronic Myeloid Leukemia

    Article • Blood, April 1999, American Society of Hematology

    Christian Thiede

  278. MYCOPHENOLATE MOFETIL AND CYCLOSPORINE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC BLOOD STEM CELL TRANSPLANTATION

    Article • Transplantation, February 1999, Wolters Kluwer Health

    Christian Thiede

  279. Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma.

    Article • Journal of Clinical Oncology, December 1998, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  280. bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer

    Article • European Journal of Cancer, July 1998, Elsevier

    Christian Thiede

  281. Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

    Article • Blood, January 1998, American Society of Hematology

    Christian Thiede

  282. What Role Does Helicobacter pylori Eradication Play in Gastric MALT and Gastric MALT Lymphoma?

    Article • Gastroenterology, December 1997, Elsevier

    Christian Thiede

  283. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group

    Article • Gastroenterology, October 1997, Elsevier

    Christian Thiede

  284. Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

    Article • JNCI Journal of the National Cancer Institute, September 1997, Oxford University Press (OUP)

    Christian Thiede

  285. Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation

    Article • British Journal of Haematology, September 1997, Wiley

    Christian Thiede

  286. The status of p53 in the metastatic progression of colorectal cancer

    Article • European Journal of Cancer, July 1997, Elsevier

    Christian Thiede

  287. Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma?

    Article • Journal of Clinical Oncology, March 1997, American Society of Clinical Oncology (ASCO)

    Christian Thiede

  288. Focal Inflammatory Infiltrations in Gastric Biopsy Specimens Are Suggestive of Crohn's Disease

    Article • Scandinavian Journal of Gastroenterology, January 1997, Taylor & Francis

    Christian Thiede

  289. MDR1 expression correlates with mutantp53 expression in colorectal cancer metastases

    Article • Journal of Cancer Research and Clinical Oncology, November 1996, Springer Science + Business Media

    Christian Thiede

  290. Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR)

    Article • Nucleic Acids Research, October 1996, Oxford University Press (OUP)

    Christian Thiede

  291. Simple and Sensitive Detection of Mutations in the Ras Proto-Oncogenes Using PNA-Mediated PCR Clamping

    Article • Nucleic Acids Research, January 1996, Oxford University Press (OUP)

    Christian Thiede

  292. Simple and Rapid Detection of Factor V Leiden by Allele-specific PCR Amplification

    Article • Thrombosis and Haemostasis, January 1996, Thieme Publishing Group

    Christian Thiede

  293. Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastases

    Article • Annals of Oncology, December 1995, Elsevier

    Christian Thiede

  294. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection

    Article • The Lancet, June 1995, Elsevier

    Christian Thiede

  295. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer

    Article • British Journal of Cancer, December 1994, Springer Science + Business Media

    Christian Thiede